Registration for NBCC’s 2025 Advocate Leadership Summit is now open! Join us at the Park Hyatt Hotel in Washington, DC, […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
Registration for NBCC’s 2025 Advocate Leadership Summit is now open! Join us at the Park Hyatt Hotel in Washington, DC, […]
This year, an estimated 42,250 women and 530 men in the United States will die of breast cancer. When […]
On WebMD, Chief Programs Officer Michelle Tregear writes: By addressing barriers and coming up with ways to increase diversity in […]
On WebMD, Chief Programs Officer Michelle Tregear writes: [Having patient] perspectives at ASCO and the bold action of patient advocates […]
Today, the House Democratic Women’s Caucus endorsed the Metastatic Breast Cancer Access to Care Act (H.R. 549), legislation that will […]
In eClinicalMedicine, an open-access clinical journal published by The Lancet, NBCC President Fran Visco and Chief Programs Officer Michelle Tregear […]
